CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
Country • Select Country
    Entity • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Deutsch ελληνικά Español Français Italiano Magyar Nederlands Polski Română Русский 简体中文 繁體中文

    Trade Asensus Surgical, Inc. - ASXC CFD

    0.2714
    2.53%
    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • Ownership
    Trading Conditions
    Spread 0.0116
    Long position overnight fee

    Long position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.026207 %
    Charges from full value of position ($-4.98)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		-0.026207%
    Short position overnight fee

    Short position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee 0.003985 %
    Charges from full value of position ($0.76)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		0.003985%
    Overnight fee time 22:00 (UTC)
    Min traded quantity 1
    Currency USD
    Margin 5%
    Stock exchange United States of America
    Commission on trade 0%

    *Information provided by Capital.com

    Asensus Surgical Inc ESG Risk Ratings

    High Medium Low Negligible

    ‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.

    More ESG coverage

    Key Stats
    Prev. Close* 0.2647
    Open* 0.2912
    1-Year Change* -28.29%
    Day's Range* 0.2692 - 0.2912
    52 wk Range 0.20-1.18
    Average Volume (10 days) 2.02M
    Average Volume (3 months) 50.29M
    Market Cap 62.11M
    P/E Ratio -100.00K
    Shares Outstanding 264.32M
    Revenue 5.61M
    EPS -0.33
    Dividend (Yield %) N/A
    Beta 1.48
    Next Earnings Date Feb 29, 2024

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Nov 27, 2023 0.2647 0.0099 3.89% 0.2548 0.2774 0.2494
    Nov 24, 2023 0.2582 0.0236 10.06% 0.2346 0.2639 0.2283
    Nov 22, 2023 0.2345 0.0012 0.51% 0.2333 0.2418 0.2297
    Nov 21, 2023 0.2315 0.0053 2.34% 0.2262 0.2433 0.2212
    Nov 20, 2023 0.2261 -0.0022 -0.96% 0.2283 0.2295 0.2215
    Nov 17, 2023 0.2318 0.0085 3.81% 0.2233 0.2369 0.2168
    Nov 16, 2023 0.2170 -0.0022 -1.00% 0.2192 0.2214 0.2124
    Nov 15, 2023 0.2171 -0.0079 -3.51% 0.2250 0.2250 0.2090
    Nov 14, 2023 0.2297 0.0022 0.97% 0.2275 0.2411 0.2092
    Nov 13, 2023 0.2067 0.0006 0.29% 0.2061 0.2144 0.2044
    Nov 10, 2023 0.2092 -0.0092 -4.21% 0.2184 0.2236 0.2068
    Nov 9, 2023 0.2174 -0.0109 -4.77% 0.2283 0.2332 0.2128
    Nov 8, 2023 0.2294 0.0010 0.44% 0.2284 0.2333 0.2256
    Nov 7, 2023 0.2292 -0.0091 -3.82% 0.2383 0.2383 0.2283
    Nov 6, 2023 0.2312 0.0029 1.27% 0.2283 0.2408 0.2262
    Nov 3, 2023 0.2194 0.0035 1.62% 0.2159 0.2299 0.2090
    Nov 2, 2023 0.2106 0.0011 0.53% 0.2095 0.2193 0.2042
    Nov 1, 2023 0.2100 -0.0149 -6.63% 0.2249 0.2258 0.2024
    Oct 31, 2023 0.2219 0.0185 9.10% 0.2034 0.2321 0.1993
    Oct 30, 2023 0.2020 -0.0099 -4.67% 0.2119 0.2153 0.2010

    Asensus Surgical, Inc. Events

    Time (UTC) Country Event
    Thursday, February 29, 2024

    Time (UTC)

    21:00

    Country

    US

    Event

    Q4 2023 Asensus Surgical Inc Earnings Release
    Q4 2023 Asensus Surgical Inc Earnings Release

    Forecast

    -

    Previous

    -
    View all events
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total revenue 7.087 8.232 3.175 8.531 24.102
    Revenue 7.087 8.232 3.175 8.531 24.102
    Cost of Revenue, Total 10.872 11.096 5.166 20.731 16.171
    Gross Profit -3.785 -2.864 -1.991 -12.2 7.931
    Total Operating Expense 82.766 70.004 63.564 163.106 73.254
    Selling/General/Admin. Expenses, Total 34.928 32.718 27.201 46.772 39.59
    Research & Development 28.942 19.348 16.621 22.468 21.823
    Depreciation / Amortization 7.708 11.254 10.801 10.301 10.868
    Unusual Expense (Income) 1.431 -2.847 0.851 72.387 -14.187
    Other Operating Expenses, Total -1.115 -1.565 2.924 -9.553 -1.011
    Operating Income -75.679 -61.772 -60.389 -154.575 -49.152
    Interest Income (Expense), Net Non-Operating 0.731 -1.761 -0.32 -1.783 -17.128
    Other, Net -0.295 1.296 -0.119 -0.967 1.126
    Net Income Before Taxes -75.243 -62.237 -60.828 -157.325 -65.154
    Net Income After Taxes -75.561 -62.462 -59.312 -154.201 -61.777
    Net Income Before Extra. Items -75.561 -62.462 -59.312 -154.201 -61.777
    Net Income -75.561 -62.462 -59.312 -154.201 -61.777
    Income Available to Common Excl. Extra. Items -75.561 -62.462 -60.023 -154.201 -61.777
    Income Available to Common Incl. Extra. Items -75.561 -62.462 -60.023 -154.201 -61.777
    Diluted Net Income -75.561 -62.462 -60.023 -154.201 -61.777
    Diluted Weighted Average Shares 236.492 226.96 70.809 17.737 15.9384
    Diluted EPS Excluding Extraordinary Items -0.31951 -0.27521 -0.84767 -8.69375 -3.87599
    Diluted Normalized EPS -0.31557 -0.28337 -0.83986 -5.88489 -4.45456
    Total Extraordinary Items
    Total Adjustments to Net Income 0 -0.711
    Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
    Total revenue 1.081 0.976 2.464 2.563 0.994
    Revenue 1.081 0.976 2.464 2.563 0.994
    Cost of Revenue, Total 3.074 2.947 2.298 4.404 2.347
    Gross Profit -1.993 -1.971 0.166 -1.841 -1.353
    Total Operating Expense 21.944 23.324 20.591 21.595 20.561
    Selling/General/Admin. Expenses, Total 9.573 10.021 8.614 8.468 8.594
    Research & Development 8.98 10.139 8.52 6.741 7.253
    Depreciation / Amortization 0.114 0.112 0.107 2.398 2.533
    Unusual Expense (Income) 0 0.999 0 0.432
    Other Operating Expenses, Total 0.203 0.105 0.053 -0.416 -0.598
    Operating Income -20.863 -22.348 -18.127 -19.032 -19.567
    Interest Income (Expense), Net Non-Operating 0.431 0.439 0.365 0.192 0.119
    Other, Net -0.242 -0.218 -0.034 -0.029 -0.086
    Net Income Before Taxes -20.674 -22.127 -17.796 -18.869 -19.534
    Net Income After Taxes -20.662 -22.218 -17.89 -18.924 -19.619
    Net Income Before Extra. Items -20.662 -22.218 -17.89 -18.924 -19.619
    Net Income -20.662 -22.218 -17.89 -18.924 -19.619
    Total Adjustments to Net Income
    Income Available to Common Excl. Extra. Items -20.662 -22.218 -17.89 -18.924 -19.619
    Income Available to Common Incl. Extra. Items -20.662 -22.218 -17.89 -18.924 -19.619
    Diluted Net Income -20.662 -22.218 -17.89 -18.924 -19.619
    Diluted Weighted Average Shares 239.57 238.28 236.849 236.713 236.505
    Diluted EPS Excluding Extraordinary Items -0.08625 -0.09324 -0.07553 -0.07994 -0.08295
    Dividends per Share - Common Stock Primary Issue 0 0 0 0
    Diluted Normalized EPS -0.08625 -0.09324 -0.07279 -0.07994 -0.08177
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total Current Assets 86.873 113.297 34.013 27.955 101.583
    Cash and Short Term Investments 70.524 98.391 16.363 9.598 72.851
    Cash & Equivalents 6.329 18.129 16.363 9.598 21.061
    Total Receivables, Net 2.81 2.06 3.985 3.336 8.595
    Accounts Receivable - Trade, Net 2.256 0.749 1.115 0.62 8.56
    Total Inventory 8.284 8.634 10.034 10.653 10.941
    Prepaid Expenses 3.584 3.255 3.631 4.368 9.196
    Total Assets 116.053 186.473 78.258 74.779 239.307
    Property/Plant/Equipment, Total - Net 14.492 16.319 11.542 7.006 6.337
    Property/Plant/Equipment, Total - Gross 27.172 26.008 25.802 17.974 17.499
    Accumulated Depreciation, Total -12.68 -9.689 -14.26 -10.968 -11.162
    Goodwill, Net 0 80.131
    Intangibles, Net 1.576 9.892 22.267 31.066 50.463
    Note Receivable - Long Term
    Other Long Term Assets, Total 9.247 9.53 10.436 8.752 0.793
    Total Current Liabilities 10.414 9.85 10.283 13.023 21.819
    Accounts Payable 3.348 3.448 1.965 3.579 4.433
    Accrued Expenses 6.601 5.859 6.301 8.553 9.228
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases 0 1.228 0
    Other Current Liabilities, Total 0.465 0.543 0.789 0.891 8.158
    Total Liabilities 16.408 17.227 16.689 19.244 70.786
    Total Long Term Debt 0 0 1.587 0 28.937
    Long Term Debt 0 1.587 0 28.937
    Deferred Income Tax 0 1.392 4.72
    Other Liabilities, Total 5.994 7.377 4.819 4.829 15.31
    Total Equity 99.645 169.246 61.569 55.535 168.521
    Common Stock 0.237 0.235 0.116 0.021 0.216
    Additional Paid-In Capital 962.731 954.649 781.397 720.484 676.373
    Retained Earnings (Accumulated Deficit) -860.935 -785.374 -722.912 -663.6 -509.406
    Treasury Stock - Common
    Other Equity, Total -2.388 -0.264 2.968 -1.37 1.338
    Total Liabilities & Shareholders’ Equity 116.053 186.473 78.258 74.779 239.307
    Total Common Shares Outstanding 236.895 235.219 116.231 20.6913 16.6413
    Short Term Investments 64.195 80.262 0 51.79
    Redeemable Preferred Stock 0 0 0
    Total Preferred Shares Outstanding 0
    Other Current Assets, Total 1.671 0.957
    Long Term Investments 3.865 37.435
    Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
    Total Current Assets 45.932 54.91 71.556 86.873 103.53
    Cash and Short Term Investments 33.089 39.972 56.434 70.524 86.351
    Cash & Equivalents 21.669 7.675 18.737 6.329 13.87
    Total Receivables, Net 0.662 1.214 1.212 2.81 3.397
    Accounts Receivable - Trade, Net 0.662 0.66 0.658 2.256 2.25
    Total Inventory 6.683 9.083 8.844 8.284 9.035
    Other Current Assets, Total 1.324 1.492 1.74 1.671 1.034
    Total Assets 70.727 78.371 96.523 116.053 128.653
    Property/Plant/Equipment, Total - Net 14.241 13.703 13.741 14.492 13.944
    Intangibles, Net 1.278 1.411 1.506 1.576 1.529
    Other Long Term Assets, Total 9.276 8.347 8.762 9.247 7.713
    Total Current Liabilities 12.123 10.647 10.877 10.414 9.844
    Accounts Payable 4.526 4.281 4.972 3.348 3.637
    Accrued Expenses 7.141 5.99 5.449 6.601 5.85
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases
    Other Current Liabilities, Total 0.456 0.376 0.456 0.465 0.357
    Total Liabilities 23.474 16.868 16.806 16.408 15.677
    Total Long Term Debt 0 0 0 0 0
    Long Term Debt
    Other Liabilities, Total 11.351 6.221 5.929 5.994 5.833
    Total Equity 47.253 61.503 79.717 99.645 112.976
    Redeemable Preferred Stock 0 0 0 0
    Common Stock 0.264 0.24 0.239 0.237 0.237
    Additional Paid-In Capital 970.952 966.335 964.162 962.731 960.676
    Retained Earnings (Accumulated Deficit) -922.133 -903.815 -883.153 -860.935 -843.045
    Other Equity, Total -1.83 -1.257 -1.531 -2.388 -4.892
    Total Liabilities & Shareholders’ Equity 70.727 78.371 96.523 116.053 128.653
    Total Common Shares Outstanding 264.111 239.97 239.342 236.895 236.783
    Total Preferred Shares Outstanding
    Short Term Investments 11.42 32.297 37.697 64.195 72.481
    Prepaid Expenses 4.174 3.149 3.326 3.584 3.713
    Long Term Investments 0 0 0.958 3.865 1.937
    Property/Plant/Equipment, Total - Gross 27.172
    Accumulated Depreciation, Total -12.68
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Net income/Starting Line -75.561 -62.462 -59.312 -154.201 -61.777
    Cash From Operating Activities -58.937 -40.659 -46.675 -73.484 -48.493
    Cash From Operating Activities 3.368 2.857 2.898 2.166 2.42
    Amortization 7.708 11.254 10.801 10.301 10.868
    Deferred Taxes 0.318 0.225 -1.516 -3.224 -3.377
    Non-Cash Items 10.185 6.24 11.171 76.825 9.288
    Cash Interest Paid 0 0 2.187 1.73
    Changes in Working Capital -4.955 1.227 -10.717 -5.351 -5.915
    Cash From Investing Activities 47.537 -119.668 -0.003 67.645 -53.481
    Capital Expenditures -1.279 -1.368 -0.003 -0.437 -0.77
    Cash From Financing Activities -0.332 161.705 53.37 -5.609 26.452
    Financing Cash Flow Items -0.35 -1.063 -0.11 -0.499 -2.432
    Issuance (Retirement) of Stock, Net 0.018 162.768 50.665 26.315 15.682
    Issuance (Retirement) of Debt, Net 0 2.815 -31.425 13.202
    Foreign Exchange Effects -0.081 0.376 0.27 0.364 -0.433
    Net Change in Cash -11.813 1.754 6.962 -11.084 -75.955
    Other Investing Cash Flow Items, Total 48.816 -118.3 0 68.082 -52.711
    Cash Taxes Paid -0.165 -0.17
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Net income/Starting Line -22.218 -75.561 -57.671 -38.747 -19.128
    Cash From Operating Activities -17.248 -58.937 -44.884 -30.23 -15.943
    Cash From Operating Activities 0.813 3.368 2.481 1.72 0.869
    Amortization 0.112 7.708 7.601 5.203 2.67
    Deferred Taxes 0.091 0.318 0.224 0.169 0.084
    Non-Cash Items 1.558 10.185 6.837 3.991 2.303
    Changes in Working Capital 2.396 -4.955 -4.356 -2.566 -2.741
    Cash From Investing Activities 29.737 47.537 41.21 23.173 23.045
    Capital Expenditures -0.064 -1.279 -0.904 -0.443 -0.246
    Cash From Financing Activities -0.483 -0.332 -0.332 -0.331 -0.336
    Financing Cash Flow Items -0.488 -0.35 -0.35 -0.349 -0.348
    Issuance (Retirement) of Stock, Net 0.005 0.018 0.018 0.018 0.012
    Foreign Exchange Effects 0.403 -0.081 -0.3 0.239 -0.045
    Net Change in Cash 12.409 -11.813 -4.306 -7.149 6.721
    Issuance (Retirement) of Debt, Net
    Other Investing Cash Flow Items, Total 29.801 48.816 42.114 23.616 23.291
    Cash Interest Paid
    Cash Taxes Paid -0.19 -0.165 0.079 0.065 -0.029
    Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
    The Vanguard Group, Inc. Investment Advisor/Hedge Fund 4.3177 11393457 -43403 2023-06-30 LOW
    BlackRock Institutional Trust Company, N.A. Investment Advisor 1.3983 3689677 44503 2023-06-30 LOW
    Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.7989 2108122 -159259 2023-06-30 LOW
    Masters Capital Management, L.L.C. Hedge Fund 0.7579 2000000 157000 2023-06-30 MED
    Biffi (Andrea) Individual Investor 0.7484 1974823 1482008 2023-04-14 HIGH
    Millennium Management LLC Hedge Fund 0.6521 1720676 -203224 2023-06-30 HIGH
    Fernando (Anthony C J) Individual Investor 0.5641 1488393 0 2023-04-14 LOW
    State Street Global Advisors (US) Investment Advisor/Hedge Fund 0.3611 952929 -4200 2023-06-30 LOW
    GSA Capital Partners LLP Hedge Fund 0.3415 901208 151408 2023-06-30 HIGH
    Milne David Bruce Individual Investor 0.2349 619884 0 2023-04-14 LOW
    UBS Financial Services, Inc. Investment Advisor 0.2231 588733 51763 2023-06-30 LOW
    SV Health Investors, LLC Venture Capital 0.1933 510142 0 2022-09-30 LOW
    AlphaCentric Advisors LLC. Investment Advisor 0.1895 500000 0 2023-06-30 HIGH
    Pacific View Asset Management, LLC Investment Advisor/Hedge Fund 0.1895 500000 0 2023-06-30 MED
    Northern Trust Investments, Inc. Investment Advisor/Hedge Fund 0.166 438092 -1490 2023-06-30 LOW
    DWS Investment Management Americas, Inc. Investment Advisor/Hedge Fund 0.1094 288600 0 2023-06-30 LOW
    Rampertab (Shameze) Individual Investor 0.0939 247863 9691 2023-07-01 LOW
    Pfenniger (Richard C Jr) Individual Investor 0.0718 189417 45000 2023-06-06 LOW
    T. Rowe Price International Ltd Investment Advisor/Hedge Fund 0.0703 185500 0 2023-06-30 LOW
    T. Rowe Price Associates, Inc. Investment Advisor 0.0703 185500 0 2023-09-30 LOW

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)
    Profit/Loss

    For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

    Asensus Surgical, Inc. Company profile

    Asensus Surgical (ASXC) is a medical device company that engages in digitising the interface between the surgeon and the patient to improve minimally invasive surgery (MIS). 

    Founded in 2006, Asensus is headquartered in Durham, North Carolina. It pioneers a new era of performance-guided surgery, using advanced capabilities, like machine vision, augmented intelligence, connectivity and robotics in laparoscopy. 

    Asensus has built the foundation of Digital Laparoscopy with the help of its Senhance Surgical System powered by the Intelligent Surgical Unit (ISU) to address clinical, cognitive and economic shortcomings in surgery.

    The Senhance Surgical System is a multi-port robotic system that provides enhanced control with surgeon eye-tracking camera control & 3D (three dimensional) HD (high definition) vision and enhances precision through tremor filtrations and robotic stabilisation. Additionally, surgeons can have enhanced focus during surgery through Asensus’s optimised ergonomics and the sense of touch (haptics). 

    The surgical device that consists of a robotic instrument and a camera for laparoscopic procedures is considered to be the smallest instrument offered in robotics, leading to smaller incisions than traditional robotic surgery. Asensus’ Senhance ultrasonic system is an advanced energy device to deliver controlled energy to ligate and divide tissue.

    Asensus Surgical previously developed the SPIDER device and the SurgiBot System. It changed its name from TransEnterix in February 2021. The company went public as TransEnterix in May 2014. It trades on the NYSE American under the ticker ‘ASXC’.

    Industry: Medical Equipment, Supplies & Distribution (NEC)

    1 Tw Alexander Drive
    Suite 160
    DURHAM
    NORTH CAROLINA 27703
    US

    Income Statement

    • Annual
    • Quarterly

    News

    A weaker Dollar drives gold higher

    Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.

    13:49, 28 November 2023

    Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain

    US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.

    13:20, 28 November 2023

    RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023

    The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.

    13:04, 28 November 2023

    Crude prices slide on OPEC+ uncertainty

    Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.

    12:55, 28 November 2023
    GBP

    UK AUTUMN BUDGET: Will Hunt cut taxes? How will GBP react this time around?

    UK Chancellor Hunt will deliver the 2023 autumn statement to MPs on Wednesday 22 November.

    10:48, 21 November 2023

    Gold Rises as Traders price-in Fed Rate Cuts

    Gold prices have declined despite a drop in Treasury yields and a weaker US Dollar. We look at the key drivers and technical levels for the gold price.

    13:17, 20 November 2023
    Gold bars

    XAU/USD Latest: Gold advances as weaker data weighs on US yields

    Gold moves higher as softer economic data weighs on US yields and the dollar

    13:43, 17 November 2023

    People also watch

    Gold

    2,041.46 Price
    +1.330% 1D Chg, %
    Long position overnight fee -0.0192%
    Short position overnight fee 0.0110%
    Overnight fee time 22:00 (UTC)
    Spread 0.50

    BTC/USD

    38,041.60 Price
    +2.540% 1D Chg, %
    Long position overnight fee -0.0616%
    Short position overnight fee 0.0137%
    Overnight fee time 22:00 (UTC)
    Spread 106.00

    Oil - Crude

    76.62 Price
    +2.000% 1D Chg, %
    Long position overnight fee -0.0187%
    Short position overnight fee -0.0032%
    Overnight fee time 22:00 (UTC)
    Spread 0.030

    US100

    16,014.00 Price
    +0.300% 1D Chg, %
    Long position overnight fee -0.0262%
    Short position overnight fee 0.0040%
    Overnight fee time 22:00 (UTC)
    Spread 7.0

    Still looking for a broker you can trust?

    Join the 570.000+ traders worldwide that chose to trade with Capital.com

    1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading